Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Devroey

Showing results (61-70 of 184) with videos related to

Pageof 19
Sort By:
Human Reproduction (Oxford, England)|October 31, 2002
Preimplantation genetic diagnosis for fragile Xa syndrome: difficult but not impossiblePeter Platteau, Karen Sermon, Sara Seneca, et al.
Human Reproduction (Oxford, England)|November 15, 2011
Are ICSI adolescents at risk for increased adiposity?Florence Belva, Rebecca Painter, Maryse Bonduelle, et al.
Fertility and Sterility|March 31, 2012
A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormoneRobert Boostanfar, Bernadette Mannaerts, Samuel Pang, et al.
Human Reproduction (Oxford, England)|April 2, 2002
Cumulative delivery rates after ICSI in women aged >37 yearsKaan Osmanagaoglu, Herman Tournaye, Efstratios Kolibianakis, et al.
Fertility and Sterility|August 9, 2005
Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 yearsPeter Platteau, Catherine Staessen, An Michiels, et al.
Reproductive Biomedicine Online|August 7, 2008
Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cyclesPeter Platteau, Anders Nyboe Andersen, Anne Loft, et al.
Fertility and Sterility|October 29, 2010
A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept studyEvangelos G Papanikolaou, Willem Verpoest, Human Fatemi, et al.
Fertility and Sterility|March 7, 2003
Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermiaValérie Vernaeve, Herman Tournaye, Kaan Osmanagaoglu, et al.
Fertility and Sterility|May 16, 2002
Effect of repeated assisted reproductive technology cycles on ovarian responseEfstratios Kolibianakis, Kaan Osmanagaoglu, Michel Camus, et al.
Fertility and Sterility|May 12, 2004
Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cyclesPeter Platteau, Johan Smitz, Carola Albano, et al.
Pageof 19

Showing results (61-70 of 184) with videos related to

Sort By:
Pageof 19
Human Reproduction (Oxford, England)|October 31, 2002
Preimplantation genetic diagnosis for fragile Xa syndrome: difficult but not impossiblePeter Platteau, Karen Sermon, Sara Seneca, et al.
Human Reproduction (Oxford, England)|November 15, 2011
Are ICSI adolescents at risk for increased adiposity?Florence Belva, Rebecca Painter, Maryse Bonduelle, et al.
Fertility and Sterility|March 31, 2012
A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormoneRobert Boostanfar, Bernadette Mannaerts, Samuel Pang, et al.
Human Reproduction (Oxford, England)|April 2, 2002
Cumulative delivery rates after ICSI in women aged >37 yearsKaan Osmanagaoglu, Herman Tournaye, Efstratios Kolibianakis, et al.
Fertility and Sterility|August 9, 2005
Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 yearsPeter Platteau, Catherine Staessen, An Michiels, et al.
Reproductive Biomedicine Online|August 7, 2008
Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cyclesPeter Platteau, Anders Nyboe Andersen, Anne Loft, et al.
Fertility and Sterility|October 29, 2010
A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept studyEvangelos G Papanikolaou, Willem Verpoest, Human Fatemi, et al.
Fertility and Sterility|March 7, 2003
Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermiaValérie Vernaeve, Herman Tournaye, Kaan Osmanagaoglu, et al.
Fertility and Sterility|May 16, 2002
Effect of repeated assisted reproductive technology cycles on ovarian responseEfstratios Kolibianakis, Kaan Osmanagaoglu, Michel Camus, et al.
Fertility and Sterility|May 12, 2004
Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cyclesPeter Platteau, Johan Smitz, Carola Albano, et al.
Pageof 19